Lack of effect of the alpha2C-adrenoceptor Del322-325 polymorphism on inhibition of cyclic AMP production in HEK293 cells.

British Journal of Pharmacology
M D Montgomery, D B Bylund

Abstract

The alpha(2C)-adrenoceptor has multiple functions, including inhibiting release of noradrenaline from presynaptic nerve terminals. A human alpha(2C) polymorphism, Del322-325, a potential risk factor for heart failure, has been reported to exhibit reduced signalling in CHO cells. To further understand the role of the Del322-325 polymorphism on receptor signalling, we attempted to replicate and further study the reduced signalling in HEK293 cells. Human alpha(2C) wild-type (WT) and Del322-325 adrenoceptors were stably transfected into HEK293 cells. Radioligand binding was performed to determine affinities for both receptors. In intact cells, inhibition of forskolin-stimulated cyclic AMP production by WT and Del322-325 clones with a range of receptor densities (200-2320 fmol.mg(-1) protein) was measured following agonist treatment. Noradrenaline, brimonidine and clonidine exhibited similar binding affinities for WT and Del322-325. Brimonidine and clonidine also had similar efficacies and potencies for both receptors for the inhibition of cyclic AMP production at all receptor densities tested. A linear regression analysis comparing efficacy and potency with receptor expression levels showed no differences in slopes between WT and D...Continue Reading

References

Jan 1, 1992·Annual Review of Neuroscience·B Kobilka
Aug 1, 1988·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·L E Limbird
Jun 9, 1994·The New England Journal of Medicine·B J Materson, D J Reda
Sep 26, 1997·Naunyn-Schmiedeberg's Archives of Pharmacology·E AgneterT J Feuerstein
Apr 22, 1999·Trends in Pharmacological Sciences·R BüscherP A Insel
Oct 11, 2002·The New England Journal of Medicine·Roger J Hajjar, Calum A MacRae
Jan 24, 2003·Annual Review of Pharmacology and Toxicology·Kersten M SmallStephen B Liggett
Sep 16, 2003·Pharmacogenetics·Julie A Johnson, John J Lima
Nov 12, 2003·Naunyn-Schmiedeberg's Archives of Pharmacology·Anne-Ulrike TrendelenburgKlaus Starke
Aug 21, 2004·Proceedings of the National Academy of Sciences of the United States of America·Kersten M SmallStephen B Liggett
Apr 5, 2005·The Journal of Pharmacology and Experimental Therapeutics·Stuart MaudsleyLouis M Luttrell
Jan 18, 2006·Annual Review of Medicine·Michel EichelbaumWilliam E Evans
Jun 29, 2006·The Journal of Pharmacology and Experimental Therapeutics·Jonathan D UrbanRichard B Mailman
Feb 27, 2007·Nature Medicine·Anastasios LymperopoulosWalter J Koch
Dec 17, 2008·Pharmacological Reviews·Dieter Rosskopf, Martin C Michel
Jan 13, 2009·British Journal of Pharmacology·Wim VrydagMartin C Michel

❮ Previous
Next ❯

Citations

Mar 20, 2014·Naunyn-Schmiedeberg's Archives of Pharmacology·Carl M HurtTimothy Angelotti
Jun 15, 2014·Pharmacological Reviews·Andrea Ahles, Stefan Engelhardt

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.